Skip to main content

In Brief This Week: Abbott; Bio-Rad Laboratories; Prometheus Laboratories; GeneGo, Sigma-Aldrich; Fluidigm

NEW YORK (GenomeWeb News) – Abbott received CE Marking in the European Union for its RealTime mS9 Colorectal cancer test, a non-invasive DNA assay that detects the methylated form of Septin 9. The assay, which runs on Abbott's m2000 PCR-based molecular diagnostic system, can be used by physicians to determine if a patient should be referred for colonoscopy. The test is not available for sale in the US, the firm noted.


Bio-Rad Laboratories this week completed its acquisition of Germany-based Biotest for €45 million ($64.5 million). The acquisition will expand bio-Rad's presence in the immunohematology testing field.


Prometheus Laboratories, which develops pharmaceuticals and personalized diagnostic products, said this week that it has executed a $260 million senior secured credit facility, consisting of a $210 million term loan and a $50 million revolving credit line.


GeneGo has included access to Sigma-Aldrich life science and chemistry products in its MetaCore 6.0, MetaDrug, and Eureka products. GeneGo said that customers could now retrieve comprehensive information on drugs and compounds and make one-click purchases from one centralized location.


The US Department of Agriculture has purchased and is using Fluidigm's microfluidic-based EP1 System to help develop and validate focused 96- and 384-SNP panels for testing dairy and beef cattle, the firm said this week.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.